FDA Grants Approval for Pantoprazole Sodium ANDA219973
The FDA has granted approval for the ANDA219973 application for Pantoprazole Sodium submitted by Shuangcheng.
Asset / Drug
Drug and asset intelligence for Shuangcheng with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Proton Pump Inhibitor
No catalysts indexed for this entity yet.
July 5, 2026 · N/A
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.